Tambocor®
Back to Test Catalogue
Flecainide, Serum/Plasma
Test ID: FLECA S
Test
Aliases/Synonyms
Method
Chromatography/Mass Spectrometry
Report Includes
Flecainide
Specimens
Avoid gel separator tubes; Serum; Plasma (EDTA)
Clinical Utility
Monitoring the Flecainide concentration is used to assure compliance and avoid toxicity of this cardiac drug used to treat ventricular tachycardia and premature contractions.
Test Location
Quest Diagnostics, California USA
Test Version
8-Sep-2023
Specimen
Specimens
Avoid gel separator tubes; Serum; Plasma (EDTA)
Sample Volume
2.0 mL
Minimum Volume
0.5 mL
Specimen Comment
Avoid gel separator tubes.
Collection & Handling
Collection Instructions
Collect trough specimen within 1 hour prior to next dose.
Handling Information
Store and send frozen.
Stability
| Ambient | 5 days |
|---|---|
| Refrigerated | 7 days |
| Frozen | 30 days |
Rejection Criteria
| Specimen | Gel-separator tube |
|---|---|
| Hemolysis | Gross |
| Lipemia | Present |
Test Version
8-Sep-2023
Performance / Interpretation
Method
Chromatography/Mass Spectrometry
Turnaround Time
11 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| Flecainide | mcg/mL |
|
||
Test Location
Quest Diagnostics, California USA
Test Version
8-Sep-2023
Interface / Setup
HL7 Interface Codes
| Order Code | Result Codes | Units |
|---|---|---|
| FLECA S | 63100FLECAINIDE | mcg/mL |
Test Version
8-Sep-2023